PExA develops, produces and markets a research instrument to study respiratory diseases such as asthma and chronic obstructive pulmonary disease, COPD. This is a simple method that collects microscopic particles, which are potential biomarkers of disease, via exhaled air in the small airways.

How PExA works

The method is like a blood sample for lungs, however it is not invasive. Lung diseases often begin with pathological changes in the small airways, but there is currently no non-invasive, user-friendly technology to measure the status in these sections of the lungs.


Product & Services

PExA provides a research instrument for lung research centres within the health services, in academia and in pharmaceutical companies, all of whom are currently actively looking for biomarkers.


Latest news

Get the latest news and press releases from PExA. Click on “read more” to access the news.